BREAKING: With Phase 3 clinical testing of the Novavax COVID-19 vaccine candidate beginning in the U.S., we have now had five vaccine candidates in the #OperationWarpSpeed portfolio launch their Phase 3 clinical trials before the end of 2020.
@SecAzar | 77,714 followers
Replying to @SecAzar
The trial is being conducted in collaboration with OWS and will enroll approximately 30,000 people at approximately 115 sites in the United States and Mexico. Some of the U.S. trial sites participating are part of the @NIAIDNews-supported COVID-19 Prevention Network.

Engagement Map



No retweeters found
21 retweeters not shown
Free access is provided to the 8 hour timeframe for this page.

A Trendsmap Explore subscription provides full access to all available timeframes

Find out more

This account is already logged in to Trendsmap.
Your subscription allows access for one user. If you require access for more users, you can create additional subscriptions.
Please Contact us if you are interested in discussing discounts for 3+ users for your organisation, or have any other queries.